Referencia:
Viesti C, Collares A, et al. 2008. Heterogeneity in the molecular basis of ACTH resistance syndrome. European Journal of Endocrinology; 159: 61-68.
PREGUNTA 2: d)
Referencia:
Chan LF, Clark AJL LA. 2008 Metherell Familial Glucocorticoid Deficiency: Advances in the Molecular Understanding of ACTH Action. Horm Res; 69: 75-82.
PREGUNTA 3: e)
Referencia:
Lin Lin, Peter C. Hindmarsh, Louise A. Metherell, et al. 2007. Severe loss-of-function mutations in the adrenocorticotropin receptor (ACTHR, MC2R) can be found in patients diagnosed with salt-losing adrenal hypoplasia Clinical Endocrinology; 66: 205-210.
PREGUNTA 4: e)
Referencia:
Lipska KJ, Bailey CJ, Inzucchi S. 2011. Use of metformin in the setting of mild-to-moderate renal inssuficiency. Diabetes Care 24: 1431-1437.
PREGUNTA 5: a)
Referencia:
Pergola PE, Raskin P, Toto RD, Meyer CJ et al for the BEAM Study investigators. 2011. Bardoloxone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med 365: 327-336.
PREGUNTA 6: d)
Referencias:
1. Nakao T, Matsumoto H, Nagaoka Y, et al. 2011. Influence of proteinuria on glycated albumin values in diabetic patients with chronic kidney disease. Intern Med 50: 23-29.
2. Peacock TP, Shihbi ZK, Bleyer AJ, et al. 2008. Comparison of glycated albumin and hemoglobin A1C levels in diabetic subjects on hemodialysis. Kidney Int 73: 1062-1068.
PREGUNTA 7: c)
Referencia:
Sammaritano LR. 2007. Therapy Insight: guidelines for selection of contraception in women with rheumatic diseases. Nature Clinical Practice Rheumatology 3 (5): 283-181.
PREGUNTA 8: b)
Referencia:
van Hylckama Vlieg A, Middeldorp S. 2011. Hormone therapies and venous hromboembolism: where are we now? J Thromb Haemost 9: 257-266.
PREGUNTA 9: c)
Referencia:
Fadel B, Ellahham S, Ringel M. 2000 Hyperthyroid heart disease. Clin Cardiol; 23: 402.
PREGUNTA 10: a)
Referencia:
Klein I, Danzi S. The cardiovascular system in thyrotoxicosis. In: Braverman LE, Utiger R, eds. Werner & ingbar's The Thyroid: A fundamental and clinical text, 9th edition. Philadelphia: Lippincott Williamas & Wilkins, 2004: 559.
PREGUNTA 11: d)
Referencia:
"The false negative rate of fine needle aspiration cytology for diagnosing thyroid carcinoma in thyroid nodules" Langenbecks Arch Surg (2010) 395: 127-132.
PREGUNTA 12: c)
Referencias:
1. Brown R, Cohen E. 2008. Novel approaches in the treatment of thyroid cancer. Update on cancer therapeutics 3; 1-11.
2. Sherman SI. 2010. Cytotoxic chemotherapy for differentiated thyroid carcinoma. Clinical Oncology 22; 464-468.